INTERNATIONAL PATENT: SHIFTBIO INC., 주식회사 시프트바이오 FILES APPLICATION FOR "INTRACELLULAR DELIVERY OF TARGET SUBSTANCE BY CD47-MEDIATED ENDOCYTOSIS"

GENEVA, Oct. 28 -- SHIFTBIO INC. ((Korea University KUR&D Center, Anam-dong 5-ga) Room637A, 145, Anam-ro,Seongbuk-guSeoul 02481), 주식회사 시프트바이오 (서울특별시성북구안암로 145, 637에이호(안암동5가, 고려대학교 케이유알앤디센터)) filed a patent application (PCT/KR2025/004555) for "INTRACELLULAR DELIVERY OF TARGET SUBSTANCE BY CD47-MEDIATED ENDOCYTOSIS" on Apr 15, 2025. With publication no. WO/2025/220930, the details related to the patent application was published on Oct 23, 2025.

Notably, the pa...